• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Lancet Reg Health Am . Extracorporeal membrane oxygenation support in children with severe coronavirus disease-2019: A case series

tetano

Editor, Senior Moderator
Lancet Reg Health Am


. 2022 Jul;11:100260.
doi: 10.1016/j.lana.2022.100260. Epub 2022 May 7.
Extracorporeal membrane oxygenation support in children with severe coronavirus disease-2019: A case series


Candice Torres de Melo Bezerra Cavalcante[SUP] 1 2 [/SUP], Andrea Consuelo de Oliveira Teles[SUP] 1 [/SUP], Isabel Cristina Leite Maia[SUP] 1 [/SUP], Valdester Cavalcante Pinto[SUP] 1 [/SUP], Jeanne Araújo Bandeira[SUP] 1 [/SUP], Emanoel Pimentel Cruz[SUP] 1 [/SUP], Raimunda Selma Antero Sousa Onofre[SUP] 1 [/SUP], Fabrício Barreira Pombo[SUP] 1 [/SUP], Marcelo Borges Cavalcante[SUP] 2 3 [/SUP], Klebia Magalhães Pereira Castello Branco[SUP] 1 [/SUP]



Affiliations

Abstract

Background: The coronavirus disease-2019 (COVID-19) pandemic has predominantly affected the adult population, but with a significantly lower prevalence in children. Most pediatric patients with COVID-19 have mild course; however, a small number progressed to acute respiratory distress syndrome, hypoxemia, despite optimized conventional therapies. Thus, this study aimed to report a series of six cases of children with severe acute respiratory syndrome coronavirus 2 infection who were supported by extracorporeal membrane oxygenation (ECMO) due to refractory hypoxemic respiratory failure.
Methods: This observational, retrospective, and descriptive study reported a series of cases. Data were retrospectively collected from the medical records of patients who were admitted to the Pediatric Cardiologic Intensive Care of Hospital Dr. Carlos Alberto Studart Gomes and Hospital Regional da Unimed, between March 1, 2020, and June 30, 2021. Sociodemographic, clinical, and laboratory data were analyzed.
Findings: The median age was 1.8 years (range: 0.4-14.5 years), 66.7% were males, and weight varied from 13 to 110 kg. The mean time between the onset of symptoms and cannulation, ECMO duration, and ventilation time were 15 days (range: 6-24 days)], 11 days (range: 6-19 days), and 20.5 days (range: 14-33 days), respectively. Five (83.3%) children were successfully decannulated and four survived with hospital discharge. One child died on ECMO support due to multiple organ dysfunction syndromes after 13 days and another one died 3 days after decannulation due to extensive hemorrhagic stroke. Our case series revealed a 33.3% in-hospital mortality rate. ECMO appears as a viable intervention in selected patients who failed conventional therapies in the pediatric population.
Funding: This observational study received no funding.

Keywords: COVID-19; Child; Extracorporeal membrane oxygenation; Respiratory distress syndrome.
 
Back
Top Bottom